Clinical Trial Design
According to clinical documents, from 3057 patients; 59 of them met the inclusion criteria, were scheduled for clinic visit screening, and enrolled in the study. Participants were randomly allocated into the celery (n=29) and placebo (n=30) groups. In the first step of the cross-over trial, 8 patients were excluded due to a change in medication regimen, and a remarkable change in physical activity and discontinuing (Figure 2). Hence, 51 patients were crossed over and completed the clinical trial.